Walleye Capital LLC Takes $536,000 Position in Anteris Technologies Global Corp. $AVR

Walleye Capital LLC bought a new position in shares of Anteris Technologies Global Corp. (NASDAQ:AVR) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 54,393 shares of the company’s stock, valued at approximately $536,000.

Other hedge funds have also recently bought and sold shares of the company. Assenagon Asset Management S.A. acquired a new position in Anteris Technologies Global during the second quarter valued at approximately $6,350,000. Militia Capital Management LLC purchased a new stake in Anteris Technologies Global during the first quarter worth approximately $3,663,000. Perceptive Advisors LLC increased its position in shares of Anteris Technologies Global by 104.4% in the first quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock worth $19,011,000 after acquiring an additional 1,750,000 shares in the last quarter. Avidity Partners Management LP purchased a new position in shares of Anteris Technologies Global in the 1st quarter valued at $832,000. Finally, Bank of America Corp DE raised its stake in shares of Anteris Technologies Global by 12.6% in the 1st quarter. Bank of America Corp DE now owns 68,755 shares of the company’s stock valued at $382,000 after acquiring an additional 7,688 shares during the period.

Anteris Technologies Global Stock Up 5.3%

AVR opened at $9.40 on Friday. The firm’s 50 day moving average is $9.13 and its 200-day moving average is $7.38. Anteris Technologies Global Corp. has a 52-week low of $3.30 and a 52-week high of $11.06. The firm has a market capitalization of $916.11 million, a P/E ratio of -4.82 and a beta of 1.78.

Anteris Technologies Global (NASDAQ:AVR) last announced its earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.09). The firm had revenue of $1.01 million during the quarter, compared to analysts’ expectations of $1.50 million. Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. During the same quarter last year, the company posted ($0.58) earnings per share. Equities analysts expect that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd sold 558,633 shares of the company’s stock in a transaction dated Thursday, July 30th. The shares were sold at an average price of $8.20, for a total value of $4,580,790.60. Following the completion of the transaction, the insider directly owned 6,633,314 shares of the company’s stock, valued at $54,393,174.80. This represents a 7.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In the last quarter, insiders have sold 3,000,659 shares of company stock valued at $25,174,702. Insiders own 4.50% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on AVR. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Barclays raised their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research report on Friday, May 15th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 target price on shares of Anteris Technologies Global in a research report on Friday. Four equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Anteris Technologies Global presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.00.

Anteris Technologies Global Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.